Exemestane: all 119 studies that test it
Page 2 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Post-Tamoxifen Exemestane TrialTerminatedNCT00810706Phase 3
- Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor TherapyStatus unknownNCT00688194Phase 3
- Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast CancerTerminatedNCT00674557Phase 2
- A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerCompletedNCT00649090Phase 4
- Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast CancerWithdrawnNCT00615524Phase 2
- Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By SurgeryStatus unknownNCT00541086Phase 3
- Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerCompletedNCT00279448Phase 3
- Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian CancerCompletedNCT00261027Phase 2
- Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer PatientsCompletedNCT00174343Phase 2
- Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast CancerWithdrawnNCT00080613Phase 2
- Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerCompletedNCT00066586Not applicable
- Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNCT00057993Phase 2
- Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal WomenTerminatedNCT00040014Phase 2
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00032136Phase 3
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate CancerCompletedNCT00031889Phase 2
- Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of TamoxifenCompletedNCT00016432Phase 3
- Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast CancerCompletedNCT00010010Phase 2
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast CancerStatus unknownNCT00003418Phase 3
- Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00002777Phase 3